Sawhney Roger — SEC insider filings
SEC reporting owner CIK 1858748. 10 insider filings on record with FilingPulse; latest filed 2026-10-07.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2021-08-03 to 2026-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 2,941 shares, $49,997 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 2,941 shares @ $17.00 ($49,997) in Omega Therapeutics, Inc., filed 2021-08-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Omega Therapeutics, Inc. (OMGA) | Chief Financial Officer | 2 | 1 leg · 2,941 sh · $49,997 | — | 1 |
| Arbutus Biopharma Corp (ABUS) | Director | 4 | — | — | 8 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | Director | 3 | — | — | 3 |
| ALIMERA SCIENCES INC (ALIM) | Director | 1 | — | — | 1 |
Insider filings — Sawhney Roger
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-07 | 4 | Arbutus Biopharma Corp (ABUS) | Disposition to issuer (D): 17,142 @ $5 | EDGAR |
| 2026-09-23 | 4 | Arbutus Biopharma Corp (ABUS) | Option exercise (M): 52,533 @ $3.34 · Option exercise (M): 78,800 @ $4.24 · Tax withholding (F): 100,508 @ $5.07 · Option exercise (M): 52,533 (derivative) @ $0 · Option exercise (M): 78,800 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Arbutus Biopharma Corp (ABUS) | Grant/award (A): 78,800 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-08-06 | 4 | Arbutus Biopharma Corp (ABUS) | Grant/award (A): 157,600 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-03-01 | 4 | ALIMERA SCIENCES INC (ALIM) | Grant/award (A): 2,252 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | Omega Therapeutics, Inc. (OMGA) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2021-08-03 | 4 | Omega Therapeutics, Inc. (OMGA) | Purchase (P): 2,941 @ $17 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-07-30 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1858748 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs